White coat effect detected using self-monitoring of blood pressure at home: Comparison with ambulatory blood pressure

American Journal of Hypertension

Volumn 11, Issue 7, 1998, Pages 820-827

  Stergiou, George S ^a   Zourbaki, Andromachi S ^a   Skeva, Irini I ^a   Mountokalakis, Theodore D ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

Ambulatory blood pressure; Home blood pressure; Isolated office hypertension; White coat effect; White coat hypertension

Indexed keywords

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HOME MONITORING; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; DATA INTERPRETATION, STATISTICAL; DIASTOLE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OFFICE VISITS; SELF CARE; SENSITIVITY AND SPECIFICITY; SYSTOLE;

EID: 0032126006     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00038-7     Document Type: Article

References (41)

1. 1. Pickering TG: White coat hypertension. Curr Opin Nephrol Hypertens 1996;5192-5198.
2. 2. Verdecchia P, Schillaci G, Borgioni C, et al: White coat hypertension and white coat effect: similarities and differences. Am J Hypertens 1995;8:790-798.
3. 3. Pickering TG, James GD, Boddie C, et al: How common is white coat hypertension? JAMA 1988;259:225-228.
4. 4. Myers MG, Reeves RA: White coat effect phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991;5:844-849.
5. 5. Myers MG: Ambulatory blood pressure monitoring in treated hypertensive patients: implications for clinical practice. J Hum Hypertens 1996;10(suppl 2):S27-S31.
6. 6. Mansoor GA, White WB: The patient with an exaggerated white-coat effect. Clinician's corner. Blood Pressure Monit 1996;1:75-77.
7. 7. O'Brien E, O'Malley K: Overdiagnosing hypertension. Br Med J 1988;297:1211-1212.
8. 8. Cavallini MC, Roman MJ, Pickering TG, et al: Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995;26: 413-419.
9. 9. Weber MA, Neutel JM, Smith DHG, Graettinger WF: Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994;90:2291-2298.
10. 10. Pierdomenico SD, Lapenna D, Guglielmi MD, et al: Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995;26:801-807.
11. 11. Perloff D, Sokolow M, Cowan R: The prognostic value of ambulatory blood pressures. JAMA 1983;249:2792-2798.
12. 12. Perloff D, Sokolow M, Cowan RM, Juster RP: Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens 1989;7(suppl 3):S3-S10.
13. 13. Verdecchia P, Porcellati C, Schillaci G, et al: Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24: 793-801.
14. 14. Pickering T, for an American Society of Hypertension Ad Hoc Panel: Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1995;9:1-11.
15. 15. World Hypertension League: Self measurement of blood pressure: a statement by the World Hypertension League. J Hypertens 1988;6:257-261.
16. 16. Aylett M: Use of home blood pressure measurements to diagnose "white coat hypertension" in general practice. J Hum Hypertens 1996;10:17-20.
17. 17. Hall CL, Higgs CM, Notarianni L, for the Bath District Hypertension Study Group: Value of patient-recorded home blood pressure series in distinguishing sustained from office hypertension: effects on diagnosis and treatment of mild hypertension. J Hum Hypertens 1990; 4(suppl 2):9-13.
18. 18. Stewart MJ, Gough K, Reid M, et al: White coat hypertension: a comparison of detection using ambulatory blood pressure monitoring or home monitoring of blood pressure (abst). Annual Scientific Meeting of the British Hypertension Society, Cambridge 1996. J Hypertens 1996;14:1507.
19. 19. Mansoor GA, McCabe EJ, White WB: Determinants of the white coat effect in hypertensive subjects. J Hum Hypertens 1996;10:87-92.
20. 20. Waeber B, Brunner HR: The patient with an exaggerated white-coat effect. Clinician's corner. Commentary. Blood Pressure Monit 1996;1:77-78.
21. 21. O'Brien E: The patient with an exaggerated white-coat effect. Clinician's corner. Commentary. Blood Pressure Monit 1996;1:78-79.
22. 22. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on the detection, evaluation and treatment of high blood pressure (JNC V). Arch Intern Med 1993;153:154-183.
23. 23. WHO/ISH: Guidelines for the management of mild hypertension: memorandum from a World Health Organisation/International Society of Hypertension meeting. J Hypertens 1993;11:905-918.
24. 24. Pickering TG: Ambulatory Monitoring and Blood Pressure Variability. Science Press, London, 1990, Part 1, pp 8.3-8.5.
25. 25. O'Brien E, Mee F, Atkins N, Thomas M: Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332 and Nissei DS-175. Blood Pressure Monit 1996;1:55-61.
26. 26. O'Brien E, Petrie J, Littler W, et al: The British Hypertension Society Protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993;11(suppl 2):S43-S63.
27. 27. Chanudet X, Phong Chau N, Larroque P: Short-term representatives of daytime and night-time ambulatory blood pressures. J Hypertens 1992;10:595-600.
28. 28. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-310.
29. 29. Verdecchia P, Schillaci G, Borgioni C, et al: Variability between current definitions of 'normal' ambulatory blood pressure. Implications in the assessment of white coat hypertension. Hypertension 1992;20:552-562.
30. 30. Armitage D, Fox W, Rose GA, Tinker CM: The variability of measurements of casual blood pressure. II. Survey experience. Clin Sci 1966;30:335-337.
31. 31. Myers MG, Oh PI, Reeves RA, Joyner CD: Prevalence of white coat effect in treated hypertensive patients in the community. Am J Hypertens 1995;8:591-597.
32. 32. Kleinert HD, Harshfield GA, Pickering TG, et al: What is the value of home blood pressure measurement in patients with mild hypertension. Hypertension 1984;6: 574-578.
33. 33. James GD, Pickering TG, Yee LS, et al: The reproducibility of average ambulatory, home, and clinic pressures. Hypertension 1988;11:545-549.
34. 34. Stergiou GS, Voutsa AV, Achimastos AD, Mountokalakis TD: Self home-monitoring of blood pressure: is fully automated oscillometric technique as good as conventional stethoscopic technique? Am J Hypertens 1997;10:428-433.
35. 35. Altman DG: Practical Statistics for Medical Research. Chapman & Hall, London, 1991, pp 409-419.
36. 36. Myers MG, Reeves RA: White coat effect in treated hypertensives patients: sex differences. J Hum Hypertens 1995;9:729-733.
37. 37. Middlemost SJ, Sack M, Davis J, et al: Effects of long-acting nifedipine on casual office blood pressure measurements, 24-hour ambulatory blood pressure profiles, exercise parameters and left ventricular mass and function in black patients with mild to moderate essential hypertension. Am J Cardiol 1992;70:474-478.
38. 38. Bidlingmeyer I, Burnier M, Bidlingmeyer M, et al: Isolated office hypertension: a prehypertensive state? J Hypertens 1996;14:327-332.
39. 39. Pickering TG, Harshfield GA, Kleinert HD, et al: Blood pressure during normal daily activities, sleep and exercise. JAMA 1982;247:992-996.
40. 40. Mancia G, Zanchetti A: White-coat hypertension: misnomers, misconceptions and misunderstandings. J Hypertens 1996;14:1049-1052.
41. 41. World Health Organization: Hypertension Control. WHO Technical Report Series 1996;862:7-8.